Show
Sort by
-
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial
-
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults
-
Persistence and immune memory to hepatitis B vaccine 20 y after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
-
Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine
-
Long-term persistence of anti-HPV-16 and-18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses